annual FCF:
$110.10M+$106.28M(+2782.88%)Summary
- As of today (May 29, 2025), ADMA annual free cash flow is $110.10 million, with the most recent change of +$106.28 million (+2782.88%) on December 31, 2024.
- During the last 3 years, ADMA annual FCF has risen by +$235.98 million (+187.46%).
- ADMA annual FCF is now at all-time high.
Performance
ADMA Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$24.39M-$71.86M(-151.39%)Summary
- As of today (May 29, 2025), ADMA quarterly free cash flow is -$24.39 million, with the most recent change of -$71.86 million (-151.39%) on March 31, 2025.
- Over the past year, ADMA quarterly FCF has dropped by -$19.82 million (-432.64%).
- ADMA quarterly FCF is now -151.39% below its all-time high of $47.47 million, reached on December 31, 2024.
Performance
ADMA quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$90.28M-$19.82M(-18.00%)Summary
- As of today (May 29, 2025), ADMA TTM free cash flow is $90.28 million, with the most recent change of -$19.82 million (-18.00%) on March 31, 2025.
- Over the past year, ADMA TTM FCF has increased by +$74.38 million (+467.56%).
- ADMA TTM FCF is now -18.00% below its all-time high of $110.10 million, reached on December 31, 2024.
Performance
ADMA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ADMA Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2782.9% | -432.6% | +467.6% |
| 3 y3 years | +187.5% | +15.5% | +175.9% |
| 5 y5 years | +237.6% | +8.7% | +197.8% |
ADMA Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +187.5% | -151.4% | +15.5% | -18.0% | +175.9% |
| 5 y | 5-year | at high | +187.5% | -151.4% | +34.3% | -18.0% | +166.8% |
| alltime | all time | at high | +187.5% | -151.4% | +34.3% | -18.0% | +166.8% |
ADMA Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$24.39M(-151.4%) | $90.28M(-18.0%) |
| Dec 2024 | $110.10M(+2782.9%) | $47.47M(+98.4%) | $110.10M(+39.7%) |
| Sep 2024 | - | $23.93M(-44.7%) | $78.82M(+19.2%) |
| Jun 2024 | - | $43.28M(-1045.0%) | $66.12M(+315.7%) |
| Mar 2024 | - | -$4.58M(-128.3%) | $15.91M(+316.5%) |
| Dec 2023 | $3.82M(-105.2%) | $16.19M(+44.2%) | $3.82M(-116.3%) |
| Sep 2023 | - | $11.23M(-262.0%) | -$23.50M(-54.3%) |
| Jun 2023 | - | -$6.93M(-58.4%) | -$51.39M(-16.1%) |
| Mar 2023 | - | -$16.67M(+49.8%) | -$61.23M(-16.6%) |
| Dec 2022 | -$73.42M(-41.7%) | -$11.13M(-33.2%) | -$73.42M(-26.2%) |
| Sep 2022 | - | -$16.67M(-0.6%) | -$99.43M(+0.5%) |
| Jun 2022 | - | -$16.77M(-41.9%) | -$98.97M(-16.8%) |
| Mar 2022 | - | -$28.86M(-22.3%) | -$118.94M(-5.5%) |
| Dec 2021 | -$125.88M(+9.7%) | -$37.14M(+129.2%) | -$125.88M(+1.1%) |
| Sep 2021 | - | -$16.20M(-55.9%) | -$124.56M(-7.8%) |
| Jun 2021 | - | -$36.74M(+2.6%) | -$135.09M(+9.1%) |
| Mar 2021 | - | -$35.80M(-0.0%) | -$123.81M(+7.9%) |
| Dec 2020 | -$114.73M(+43.4%) | -$35.82M(+34.0%) | -$114.73M(+14.5%) |
| Sep 2020 | - | -$26.74M(+5.0%) | -$100.16M(+1.1%) |
| Jun 2020 | - | -$25.45M(-4.7%) | -$99.02M(+7.2%) |
| Mar 2020 | - | -$26.72M(+25.8%) | -$92.33M(+15.4%) |
| Dec 2019 | -$80.01M(+23.5%) | -$21.25M(-17.0%) | -$80.01M(+2.1%) |
| Sep 2019 | - | -$25.60M(+36.5%) | -$78.37M(+19.6%) |
| Jun 2019 | - | -$18.76M(+30.3%) | -$65.54M(+5.4%) |
| Mar 2019 | - | -$14.40M(-26.6%) | -$62.19M(-4.0%) |
| Dec 2018 | -$64.77M(+62.1%) | -$19.61M(+53.5%) | -$64.77M(+7.0%) |
| Sep 2018 | - | -$12.77M(-17.1%) | -$60.53M(+4.2%) |
| Jun 2018 | - | -$15.41M(-9.3%) | -$58.07M(+12.7%) |
| Mar 2018 | - | -$16.98M(+10.5%) | -$51.53M(+29.0%) |
| Dec 2017 | -$39.95M | -$15.37M(+49.1%) | -$39.95M(+41.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$10.31M(+16.2%) | -$28.20M(+24.9%) |
| Jun 2017 | - | -$8.87M(+64.2%) | -$22.58M(+21.7%) |
| Mar 2017 | - | -$5.40M(+49.1%) | -$18.56M(+1.2%) |
| Dec 2016 | -$18.34M(+18.8%) | -$3.62M(-22.7%) | -$18.34M(-2.4%) |
| Sep 2016 | - | -$4.69M(-3.2%) | -$18.79M(+12.0%) |
| Jun 2016 | - | -$4.84M(-6.6%) | -$16.79M(+2.4%) |
| Mar 2016 | - | -$5.19M(+27.3%) | -$16.39M(+6.2%) |
| Dec 2015 | -$15.44M(-9.3%) | -$4.07M(+51.9%) | -$15.44M(+4.1%) |
| Sep 2015 | - | -$2.68M(-39.8%) | -$14.83M(-7.4%) |
| Jun 2015 | - | -$4.45M(+5.2%) | -$16.01M(-0.6%) |
| Mar 2015 | - | -$4.24M(+22.4%) | -$16.11M(-5.4%) |
| Dec 2014 | -$17.03M(+53.6%) | -$3.46M(-10.4%) | -$17.03M(+3.0%) |
| Sep 2014 | - | -$3.86M(-15.2%) | -$16.53M(+10.9%) |
| Jun 2014 | - | -$4.55M(-11.6%) | -$14.91M(+13.9%) |
| Mar 2014 | - | -$5.15M(+73.8%) | -$13.10M(+18.1%) |
| Dec 2013 | -$11.08M(+57.8%) | -$2.97M(+32.3%) | -$11.08M(+11.3%) |
| Sep 2013 | - | -$2.24M(-18.0%) | -$9.96M(+1.2%) |
| Jun 2013 | - | -$2.74M(-12.9%) | -$9.85M(+20.6%) |
| Mar 2013 | - | -$3.14M(+70.5%) | -$8.16M(+16.3%) |
| Dec 2012 | -$7.02M(>+9900.0%) | -$1.84M(-13.4%) | -$7.02M(+35.2%) |
| Sep 2012 | - | -$2.13M(+102.1%) | -$5.19M(+69.2%) |
| Jun 2012 | - | -$1.05M(-47.3%) | -$3.07M(+51.6%) |
| Mar 2012 | - | -$2.00M(>+9900.0%) | -$2.02M(+6739.2%) |
| Dec 2011 | - | -$12.80K(+146.2%) | -$29.60K(+14.7%) |
| Sep 2011 | - | -$5200.00(-32.5%) | -$25.80K(-11.0%) |
| Jun 2011 | -$29.00K(+47.2%) | -$7700.00(+97.4%) | -$29.00K(+36.2%) |
| Mar 2011 | - | -$3900.00(-56.7%) | -$21.30K(+22.4%) |
| Dec 2010 | - | -$9000.00(+7.1%) | -$17.40K(+107.1%) |
| Sep 2010 | - | -$8400.00 | -$8400.00 |
| Jun 2010 | -$19.70K | - | - |
FAQ
- What is ADMA Biologics annual free cash flow?
- What is the all time high annual FCF for ADMA Biologics?
- What is ADMA Biologics annual FCF year-on-year change?
- What is ADMA Biologics quarterly free cash flow?
- What is the all time high quarterly FCF for ADMA Biologics?
- What is ADMA Biologics quarterly FCF year-on-year change?
- What is ADMA Biologics TTM free cash flow?
- What is the all time high TTM FCF for ADMA Biologics?
- What is ADMA Biologics TTM FCF year-on-year change?
What is ADMA Biologics annual free cash flow?
The current annual FCF of ADMA is $110.10M
What is the all time high annual FCF for ADMA Biologics?
ADMA Biologics all-time high annual free cash flow is $110.10M
What is ADMA Biologics annual FCF year-on-year change?
Over the past year, ADMA annual free cash flow has changed by +$106.28M (+2782.88%)
What is ADMA Biologics quarterly free cash flow?
The current quarterly FCF of ADMA is -$24.39M
What is the all time high quarterly FCF for ADMA Biologics?
ADMA Biologics all-time high quarterly free cash flow is $47.47M
What is ADMA Biologics quarterly FCF year-on-year change?
Over the past year, ADMA quarterly free cash flow has changed by -$19.82M (-432.64%)
What is ADMA Biologics TTM free cash flow?
The current TTM FCF of ADMA is $90.28M
What is the all time high TTM FCF for ADMA Biologics?
ADMA Biologics all-time high TTM free cash flow is $110.10M
What is ADMA Biologics TTM FCF year-on-year change?
Over the past year, ADMA TTM free cash flow has changed by +$74.38M (+467.56%)